InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,075.18
(
1.29%
)
US TECH 100
17,043.20
(
1.73%
)
Dow Jones
38,517.74
(
0.73%
)
Brent Oil
87.55
(
1.31%
)
Bitcoin
66,723.47
(
-0.20%
)
Post# of 251571
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119451
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Double_Bagel post# 220475

Monday, 08/13/2018 11:08:59 AM

Monday, August 13, 2018 11:08:59 AM

Post# of 251571
Re: HCV in China

Mayvret is not on this list [of “urgently needed” drugs in China]. Epclusa, Sovaldi, Vosevi and Harvoni are all on this list.

Actually, Epclusa was approved in China three months ago (#msg-141163957), and it is not on the list of 48 drugs you referenced.

Why is Mavyret not on the list? I don’t know, but I would not infer from its absence on the list that China is uninterested in the product.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up